结缔组织增生性色素痣四例临床病理分析

中华皮肤科杂志 ›› 2017, Vol. 50 ›› Issue (7): 503-507.

结缔组织增生性色素痣四例临床病理分析

张倩¹,苏静²,³,柳剑英²,³,高菲²,³,梅放¹,叶蒙蒙⁴,张伟⁵

1. 北京大学医学部基础医学院病理学系/北京大学第三医院病理科
2. 北京大学医学部病理系，北京大学第三医院病理科
3. 北京大学医学部病理系，北京大学第三医院病理科
4. 北京市昌平区医院病理科
5. 北京市怀柔区医院病理科

收稿日期:2016-10-09 修回日期:2017-03-03 发布日期:2017-07-03
通讯作者: 柳剑英 E-mail:liujianying@bjmu.edu.cn

Clinicopathologic analysis of four cases of desmoplastic melanocytic nevus

Received:2016-10-09 Revised:2017-03-03 Published:2017-07-03

摘要/Abstract

摘要： 目的探讨结缔组织增生性色素痣的病理学特点及鉴别诊断。方法对4例皮肤结缔组织增生性色素痣的临床表现、组织学表现、免疫组化及荧光原位杂交（FISH）特点进行分析。结果 4例结缔组织增生性色素痣中，男2例，女2例，年龄19～30岁，平均26.5岁；皮损位于四肢3例，外阴1例。组织学特点：均为皮内痣，病变左右对称，痣细胞呈上皮样和（或）梭形，聚集成团或单个散在分布于增生的纤维组织之间，均未见淋巴细胞聚集、坏死或溃疡。免疫组化显示，3例痣细胞为S100和Melan A阳性，2例为P16阳性；Ki?67阳性指数均小于5%；2例间质细胞为凝血因子F??和CD34阴性。荧光原位杂交（FISH）显示结缔组织增生性色素痣在6p25（RREB1）、6q23（MYB）、6p11.1?q11.1（Cep6）及11q13（CCND1）4个基因位点均无拷贝数异常。结论结缔组织增生性色素痣是一种组织学独特的良性黑素细胞痣，ki?67、S100、Melan A、凝血因子F??等免疫组化染色和黑素瘤FISH检测有助于其与皮肤纤维组织细胞瘤和黑素瘤鉴别。

Abstract: Zhang Qian1, Su Jing, Liu Jianying, Gao Fei, Mei Fang, Zhang Qian 2, Ye Mengmeng, Zhang Wei Department of Pathology, Peking University School of Basic Medical Sciences, Beijing 100191, China （Zhang Q 1, Su J, Liu JY, Gao F, Mei F）; Department of Dermatology, Peking University Third Hospital, Beijing 100191, China （Zhang Q 2）; Department of Pathology, Beijing Changping Hospital, Beijing 102200, China （Ye MM）; Department of Pathology, Beijing Huairou Hospital, Beijing 101400, China （Zhang W） Corresponding author: Liu Jianying, Email: liujianying@bjmu.edu.cn 【Abstract】 Objective To investigate pathological characteristics and differential diagnosis of desmoplastic melanocytic nevus. Methods Four cases of desmoplastic melanocytic nevus were analyzed based on the clinical manifestations and histological, immunohistochemical and fluorescence in situ hybridization （FISH） features. Results Of the 4 cases, 2 were male and 2 were female. Their age ranged from 19 to 30 years with the average age being 26.5 years. The skin lesions were located on the extremities in 3 cases, on the vulva in 1 case. Histologically, the lesions were bilaterally symmetrical intradermal nevus. Nevus cells appeared epithelioid and/or fusiform, some were clustered or scattered in the proliferative fibrous tissue. None of lymphocyte aggregation, necrosis or ulceration was observed. Immunohistochemical examination showed positive staining for S100 and Melan A in 3 cases, positive staining for P16 in 2 cases, Ki?67?labeling index less than 5% in all the 4 cases, and negative staining for factor XIII （FXIII） and CD34 in 2 cases. FISH assay showed no copy?number variations in gene loci 6p25 （RREB1）, 6q23 （MYB）, 6p11.1?q11.1 （Cep6） and 11q13 （CCND1） in desmoplastic melanocytic nevus. Conclusion Desmoplastic melanocytic nevus is a kind of histologically unique, benign melanocytic nevus, and immunohistochemical staining for Ki?67, S?100, Melan A and F??and FISH assay on melanoma can be helpful for the differential diagnosis between cutaneous fibrous histiocytoma and melanoma.

张倩苏静柳剑英高菲梅放叶蒙蒙张伟. 结缔组织增生性色素痣四例临床病理分析[J]. 中华皮肤科杂志, 2017,50(7):503-507. doi:

参考文献 15

［1］	Ferrara G，Brasiello M，Annese P, et al. Desmoplastic nevus: clinicopathologic keynotes［J］. Am J Dermatopathol, 2009, 31（7）:718⁃722. DOI: 10.1097/DAD.0b013e3181a9f0ee.
［2］	Reed RJ, Ichinose H, Clark WH, et al. Common and uncommon melanocytic nevi and borderline melanomas［J］. Semin Oncol, 1975, 2（2）: 119⁃147.
［3］	Mackie RM, Doherty VR. The desmoplastic melanocytic naevus: a distinct histological entity［J］. Histopathology, 1992, 20（3）: 207⁃211. DOI: 10.1111/j.1365⁃2559.1992.tb00958.x.
［4］	Harris GR, Shea CR, Horenstein MG, et al. Desmoplastic （sclerotic） nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma［J］. Am J Surg Pathol, 1999, 23（7）: 786⁃794. DOI: 10.1097/00000478⁃199907000⁃00006.
［5］	Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan⁃A and Ki⁃67 in desmoplastic melanoma and desmoplastic nevi［J］. Am J Dermatopathol, 2004, 26（6）: 452⁃457.
［6］	Sherrill AM, Crespo G, Prakash AV, et al. Desmoplastic nevus: an entity distinct from spitz nevus and blue nevus［J］. Am J Dermatopathol, 2011, 33（1）: 35⁃39. DOI: 10.1097/DAD. 0b013e3181e5dfa0.
［7］	Gerami P, Beilfuss B, Haghighat Z, et al. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi［J］. J Cutan Pathol, 2011, 38（4）: 329⁃334. DOI: 10.1111/j.1600⁃0560. 2010.01666.x.
［8］	Sidiropoulos M, Sholl LM, Obregon R, et al. Desmoplastic nevus of chronically sun⁃damaged skin: an entity to be distinguished from desmoplastic melanoma［J］. Am J Dermatopathol, 2014, 36（8）: 629⁃634. DOI: 10.1097/DAD.0000000000000069.
［9］	Calonje E, Brenn T, Lazar A, et al. 临床皮肤病理学［M］. 朱学骏, 孙建方, 译. 北京: 北京大学医学出版社, 2007: 1276⁃1277.
［10］	Patel SG, Coit DG, Shaha AR, et al. Sentinel lymph node biopsy for cutaneous head and neck melanomas［J］. Arch Otolaryngol Head Neck Surg, 2002, 128（3）: 285⁃291.
［11］	廖松林, 薛卫成, 柳剑英.皮肤肿瘤病理学及遗传学［M］. 北京:人民卫生出版社, 2006: 78⁃81.
［12］	Paradela S, Fonseca E, Pita S, et al. Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool［J］. J Cutan Pathol, 2009, 36（7）: 740⁃752. DOI: 10.1111/j.1600⁃0560.2008. 01153.x.
［13］	Blokhin E, Pulitzer M, Busam KJ. Immunohistochemical expres⁃sion of p16 in desmoplastic melanoma［J］. J Cutan Pathol, 2013, 40（9）: 796⁃800. DOI: 10.1111/cup.12186.
［14］	黄玲, 雷观鲁, 周光平, 等. P16蛋白表达与原发性皮肤恶性黑素瘤的相关研究［J］. 中华皮肤科杂志, 2001, 34（3）: 220. DOI: 10.3760/j.issn:0412⁃4030.2001.03.025.
［15］	苏静, 柳剑英, 郑杰, 等. 多基因组合荧光原位杂交在皮肤恶性黑色素瘤辅助诊断中的应用［J］. 中华病理学杂志, 2015, 44（1）: 37⁃41. DOI: 10.3760/cma.j.issn.0529⁃5807.2015.01.008.